Evidence map›Paper›PMID 42045554›Full record

ArticleCommunications biology2026

Cytometric proteome profiling of GFP-tagged yeast for characterizing novel antifungals.

Eslam Ghazy, Victoria A Bidiuk, Fedor Ryabov, Olga V Mitkevich, Olga B Riabova, Yaroslav M Stanishevskiy, Igor B Levshin, Liudmila A Alexandrova, Maxim V Jasko, Dmitriy A Makarov and 7 more

Abstract read
In one paragraph

Article in Communications biology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

17 authors.

Eslam Ghazy *Department of Microbiology and Immunology, Faculty of Pharmacy, Tanta University, Tanta, Egypt.
Victoria A Bidiuk *Federal Research Center of Biotechnology of the RAS, Moscow, Russia.
Fedor RyabovFederal Research Center of Biotechnology of the RAS, Moscow, Russia.ORCID http://orcid.org/0000-0001-8728-9465
Olga V MitkevichFederal Research Center of Biotechnology of the RAS, Moscow, Russia.
Olga B RiabovaFederal Research Center of Biotechnology of the RAS, Moscow, Russia.ORCID http://orcid.org/0000-0002-3794-6495
Yaroslav M StanishevskiyInstitute of Biochemical Technology and Nanotechnology, Peoples' Friendship University of Russia (RUDN), Moscow, Russia.
Igor B LevshinGause Institute of New Antibiotics, Moscow, Russia.
Liudmila A AlexandrovaEngelhardt Institute of Molecular Biology RAS, Moscow, Russia.
Maxim V JaskoEngelhardt Institute of Molecular Biology RAS, Moscow, Russia.
Dmitriy A MakarovEngelhardt Institute of Molecular Biology RAS, Moscow, Russia.
Alexander A ZhgunFederal Research Center of Biotechnology of the RAS, Moscow, Russia.
Darya A AvdaninaFederal Research Center of Biotechnology of the RAS, Moscow, Russia.
Anna A ErmolyukFederal Research Center of Biotechnology of the RAS, Moscow, Russia.
Vitaly V KushnirovFederal Research Center of Biotechnology of the RAS, Moscow, Russia.
Anna P EgorovaFederal Research Center of Biotechnology of the RAS, Moscow, Russia.ORCID http://orcid.org/0000-0002-6708-2421
Michael O AgaphonovFederal Research Center of Biotechnology of the RAS, Moscow, Russia. agaphonov@inbi.ras.ru.ORCID http://orcid.org/0000-0002-9270-9476
Alexander I AlexandrovFederal Research Center of Biotechnology of the RAS, Moscow, Russia. aleksandr.aleksandrov@unige.ch.ORCID http://orcid.org/0000-0001-7250-4740

Funding

Russian Science Foundation (RSF) #21-74-10115Russian Science Foundation (RSF) #22-23-00160Russian Science Foundation (RSF) #22-24-00756
6 · The paper itself

Abstract

Assaying cellular responses to antimicrobial molecules is one way to understand modes of action of potential drugs. This is often achieved via transcriptomics and proteomics, but simple, inexpensive methods for rapid characterization are lacking. To bridge this gap, we assayed changes in the abundance of a panel of 64 "sentinel" proteins fused to GFP in the yeast Saccharomyces cerevisiae using flow cytometry. This method produced expected patterns for classical antifungals and allowed inference of common mechanisms between known and novel compounds. Single-cell data also revealed diverging responses in mitochondrial protein abundance in response to thiazolidine antifungals, and perturbations of the cell cycle caused by various compounds. Finally, the method provided insight into the unknown mode of action of alkylated nucleosides, which can be used against fungi residing on works of art. These substances elevate levels of proteins involved in the biosynthesis of aromatic amino acids (AAA), as well as in oxidative stress. Furthermore, deficiencies of Trp and Tyr biosynthesis increased the efficacy of these compounds, while antioxidants reduced it. Most surprisingly, antioxidant effectiveness relied on AAA biosynthesis. Thus, our approach and its possible modifications for other microbes provide an easy and reliable platform for revealing modes of action of novel compounds.

Indexed as

Antifungal AgentsFlow CytometryGreen Fluorescent ProteinsProteomeProteomicsSaccharomyces cerevisiaeSaccharomyces cerevisiae ProteinsAntifungal AgentsGreen Fluorescent ProteinsProteomeSaccharomyces cerevisiae Proteins

Identifiers

PMID42045554
PMCPMC13324700

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.